< Back to latest news & events

News

HGF launches forward-thinking and inclusive parental leave policy – PRESS RELEASE

September 2024

This policy positions HGF as the first Intellectual Property firm in the UK to provide all eligible colleagues, irrespective of gender with access to the best parental leave and pay offering, including up to 52 weeks’ leave with 26 weeks at full pay.

Launching today, the new policy offers all eligible new parents in the UK, irrespective of gender or family circumstance, access to:

  • Up to 52 weeks’ of leave with 26 weeks at full pay.
  • Spread leave and pay to suit personal circumstances, leave can be taken in one block or in discontinuous blocks and pay can be spread equally.
  • Leave and pay that is not impacted if taking time off simultaneously with the other parent (where there is more than one parent).
  • Pro rata’d billing targets, for colleagues in fee-earning positions billing targets are reduced in the relevant financial year/s.

The policy applies each time an eligible colleague in the UK welcomes a new child or additional children into their family.

Martyn Fish, CEO commented: “I am personally proud and delighted that HGF is leading in its sector and the broader business community by introducing this progressive new policy. This is going to make a real impact on our colleagues”

Lara Robinson, Deputy HR Director commented: “This is a momentous move in supporting new parents at HGF. This policy helps to level the playing field in providing every eligible colleague the opportunity to be involved in this special time with their new child/ren whilst still being able to progress in their careers, reinforcing HGF’s commitment to creating a workplace where every individual can thrive both personally and professionally”.

If you have any queries or require any additional information please contact marketing@hgf.com

Latest updates

Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article